Medifast (0K05.L) Stock Price
$14.24 0%
to add to portfolio
AI Score
-
Alternative
4 -
Fundamental
6 -
Technical
4
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Medifast, AI stock picks, stock alerts and much more.
0K05.L AI Stock Analysis
AI stock analysis for 0K05.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Medifast (0K05.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Medifast (0K05.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Medifast (0K05.L), currently trading at $14.24, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About 0K05.L
-
Medifast, Inc.
-
Symbol
0K05.L
-
Market
LSE
-
Industry
Personal Products & Services
-
Market Cap
156.5M
Similar Stocks
 |
CVS Group CVSG.L |
£1292 1.9% |
6 |
 |
XPS Pensions Group XPS.L |
£367 1.1% |
7 |
 |
Mears Group MER.L |
£354.5 0.7% |
6 |
 |
H&R Block 0HOB.L |
$52.1 1.6% |
5 |
News
0K05.L Alternative Data
Web Traffic
Medifast receives an estimated 10104 monthly visitors to medifastinc.com.
-
Web Traffic
10104
-
Change from Previous Month
15%
-
3 Month Change
52.9%
-
YoY Change
52.9%
Facebook Engagement
Medifast has engaged 3 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
3
-
Daily Change
200%
-
1 Month Change
50%
-
3 Month Change
0%
Instagram Followers
Medifast has 9,549 Instagram Followers on its main Instagram account, down by -0.1% over the last month.
-
Instagram Followers
9549
-
Daily Change
0%
-
1 Month Change
0.1%
-
3 Month Change
0.3%
Youtube Subscribers
Medifast has 3,060 subscribers on its main Youtube channel.
-
Youtube Subscribers
3060
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Job Postings
Medifast has an estimated 5 open job postings, which is down -16.7% over the last month.
-
Job Postings
5
-
Daily Change
0%
-
1 Month Change
16.7%
-
3 Month Change
28.6%
-
YoY Change
28.6%
Reddit Mentions
Medifast has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Twitter Followers
Medifast has 8,571 Twitter Followers on its main Twitter (also known as X) account, which is down by -0% over the last month.
-
Twitter Followers
8571
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0.3%
-
YoY Change
0.3%
LinkedIn Followers
27,521 are following Medifast on LinkedIn, up by 0.2% over the last month.
-
LinkedIn Followers
27521
-
Daily Change
0.2%
-
1 Month Change
0.2%
-
3 Month Change
0.4%
-
YoY Change
0.4%
LinkedIn Employees
According to LinkedIn, Medifast has 1,370 employees, down by -0.4% over the last month.
-
LinkedIn Employees
1370
-
Daily Change
0.4%
-
1 Month Change
0.4%
-
3 Month Change
1.3%
-
YoY Change
1.3%
Business Outlook
According to employee reviews, the business outlook among employees at Medifast is 54 out of 100 (neutral).
-
Business Outlook
54
-
Change from Previous Month
0%
-
3 Month Change
3.6%
-
YoY Change
3.6%
News Mentions
Medifast was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
0K05.L Financials
0K05.L Key Metrics
-
Total Revenue
$115.7M
-
Net Income
-$772K
-
Earnings per Share
-$0.07
-
Free cash flow
$1.9M
-
EBITDA
$3.8M
-
EBITDA Ratio
0.0328875
-
Total Assets
$280M
0K05.L 2-year Revenue & Income
0K05.L 2-year Free Cash Flow
0K05.L Technicals
0K05.L SMA
0K05.L RSI
FAQ
What's the current price of Medifast (0K05.L) Stock?
The price of an Medifast (0K05.L) share is $14.24.
What's the market cap of Medifast?
The current market cap of Medifast is 156.5M.
Should I buy or sell 0K05.L?
Medifast shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Medifast is better viewed as a hold or accumulate position while waiting for further developments.
Is Medifast a good investment?
The current analysis of Medifast's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Medifast's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Medifast (0K05.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Medifast stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Medifast (0K05.L) that investors often compare it to?
Medifast (0K05.L) is often compared to similar stocks such as CVS Group, XPS Pensions Group, Mears Group and H&R Block.
What is the forecast for Medifast's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Medifast's stock price to be around $13.84 in 2026. Starting from the current price of $14.24, this represents a 2.8% change in price, indicating a neutral outlook for the stock.
How to buy Medifast (0K05.L) Stock?
Medifast stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Medifast shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.